Host responses to mucosal biofilms in the lung and gut

Mucosal Immunol. 2020 May;13(3):413-422. doi: 10.1038/s41385-020-0270-1. Epub 2020 Feb 28.

Abstract

The impact of the human microbiome on health and disease is of utmost importance and has been studied intensively in recent years. Microbes promote immune system development and are essential to the production and absorption of nutrients for the host but are also implicated in disease pathogenesis. Particularly, bacterial biofilms have long been recognized as contributors to chronic infections and diseases in humans. However, our understanding of how the host responds to the presence of biofilms, specifically the immune response to biofilms, and how this contributes to disease pathogenesis is limited. This review aims to highlight what is known about biofilm formation and in vivo models available for the biofilm study. We critique the contribution of biofilms to human diseases, focusing on the lung diseases, cystic fibrosis and chronic obstructive pulmonary disease, and the gut diseases, inflammatory bowel disease and colorectal cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biofilms* / growth & development
  • Disease Susceptibility
  • Gastrointestinal Microbiome / immunology*
  • Host-Pathogen Interactions / immunology*
  • Humans
  • Immunity, Mucosal
  • Inflammatory Bowel Diseases / etiology
  • Inflammatory Bowel Diseases / metabolism
  • Inflammatory Bowel Diseases / pathology
  • Microbiota / immunology*
  • Models, Biological
  • Respiratory Mucosa / immunology*
  • Respiratory Mucosa / microbiology*